AIMS: To determine the recurrence rate after pterygium excision with ipsilateral conjunctival autograft using fibrin glue. METHODS: One hundred eleven eyes of 92 patients operated for primary pterygium were retrospectively evaluated for recurrence rate and intraoperative and postoperative complications. Pterygia were preoperatively divided in atrophic/grade 1 (n = 2; 1.80%), intermediate/grade 2 (n = 85; 76.58%), or fleshy/grade 3 (n = 24; 21.62%) types. All patients were operated using an ipsilateral conjunctival autograft fixed with fibrin glue. Only patients with 2-year follow-up were included in this study. RESULTS: Two years after surgery, the mean recurrence rate was 4.50% (n = 5). No intraoperative complications were noted. Postsurgical complications were graft pseudoedema (n = 45; 40.54%), graft retraction (n = 3; 2.70%), and donor site granuloma (n = 1; 0.90%). CONCLUSION: Fibrin glue-assisted ipsilateral conjunctival autograft seems to be safe and efficacious and associated with a low rate of recurrence.
AIMS: To determine the recurrence rate after pterygium excision with ipsilateral conjunctival autograft using fibrin glue. METHODS: One hundred eleven eyes of 92 patients operated for primary pterygium were retrospectively evaluated for recurrence rate and intraoperative and postoperative complications. Pterygia were preoperatively divided in atrophic/grade 1 (n = 2; 1.80%), intermediate/grade 2 (n = 85; 76.58%), or fleshy/grade 3 (n = 24; 21.62%) types. All patients were operated using an ipsilateral conjunctival autograft fixed with fibrin glue. Only patients with 2-year follow-up were included in this study. RESULTS: Two years after surgery, the mean recurrence rate was 4.50% (n = 5). No intraoperative complications were noted. Postsurgical complications were graft pseudoedema (n = 45; 40.54%), graft retraction (n = 3; 2.70%), and donor site granuloma (n = 1; 0.90%). CONCLUSION: Fibrin glue-assisted ipsilateral conjunctival autograft seems to be safe and efficacious and associated with a low rate of recurrence.
Authors: Engin Bilge Ozgurhan; Necip Kara; Ercument Bozkurt; Baran Gencer; Alper Agca; Zeynep Alkin; Ahmet Demirok Journal: Biomed Res Int Date: 2013-06-20 Impact factor: 3.411
Authors: Engin Bilge Ozgurhan; Necip Kara; Ercument Bozkurt; Baran Gencer; Kemal Yuksel; Ahmet Demirok Journal: Indian J Ophthalmol Date: 2014-06 Impact factor: 1.848